⟳ 3D Preview
🔒Sequence protected. Public page contains rendered media only; no sequence or raw aptamer PDB is supplied.
APTFAB catalogue item
Anti-IL-6 Aptamer
APT-IL6-002
Research Use Commercial Licence Available Binding Verified
A research aptamer developed against Interleukin-6 for inflammation-associated studies.
Price: Request quotation
Datasheet unavailable
Target Details
- Target Name
- Interleukin-6
- Scientific Name
- Interleukin-6
- Target Type
- Protein
- Organism
- Human
- UniProt ID
- P05231
- PDB ID
- 1ALU
- Molecular Weight
- ~21 kDa
Aptamer Characteristics
- Aptamer Type
- DNA
- Length
- 44 nt
- Binding Format
- Single binder
- Sequence
- Not publicly disclosed
- Intended Use
- Research Use, Commercial Licensing
Chemical Modification
Verification & Validation
- Methods
- BLI, Docking
- Validation Level
- Binding Verified
- Sample Matrix
- PBS
- Affinity
- Available upon request
Applications
Suitable for affinity research and platform-development studies involving Interleukin-6.
- Target-specific research positioning
- Custom labelling available
This aptamer is positioned for the following research and development applications:
InflammationResearch
Additional platform-specific validation may be required before diagnostic, therapeutic, or regulated use.
Research use: Available for research projects, assay development, and proof-of-concept studies.
Commercial use: Commercial licensing and platform integration may be discussed through enquiry.
Sequence access: The proprietary nucleotide sequence is not displayed or sent to the public browser.